Want to see TSE:RAMM full AI Analyst Report?
Total Valuation
Ramm Pharma has a market cap or net worth of C$1.19M. The enterprise value is C$866.77K.
Market CapC$1.19M
Enterprise ValueC$866.77K
Share Statistics
Ramm Pharma has 119,389,320 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding119,389,320
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Ramm Pharma’s return on equity (ROE) is -1.56 and return on invested capital (ROIC) is -77.26%.
Return on Equity (ROE)-1.56
Return on Assets (ROA)-0.96
Return on Invested Capital (ROIC)-77.26%
Return on Capital Employed (ROCE)-0.79
Revenue Per Employee10.00T>
Profits Per Employee-10.00T>
Employee Count―
Asset Turnover0.36
Inventory Turnover3.21
Valuation Ratios
The current PE Ratio of Ramm Pharma is ―. Ramm Pharma’s PEG ratio is 0.00430.
PE Ratio―
PS Ratio0.53
PB Ratio0.31
Price to Fair Value0.31
Price to FCF-1.69
Price to Operating Cash Flow―
PEG Ratio0.00430
Income Statement
In the last 12 months, Ramm Pharma had revenue of 3.36M and earned -8.91M in profits. Earnings per share was -0.07.
Revenue3.36M
Gross Profit373.93K
Operating Income-4.52M
Pretax Income-8.89M
Net Income-8.91M
EBITDA-3.78M
Earnings Per Share (EPS)-0.07
Cash Flow
In the last 12 months, operating cash flow was -1.06M and capital expenditures 5.00, giving a free cash flow of -1.06M billion.
Operating Cash Flow-1.06M
Free Cash Flow-1.06M
Free Cash Flow per Share>-0.01
Dividends & Yields
Ramm Pharma pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-2.93
52-Week Price Change0.00%
50-Day Moving Average0.02
200-Day Moving Average0.03
Relative Strength Index (RSI)8.17
Average Volume (3m)118.29K
Important Dates
Ramm Pharma upcoming earnings date is Sep 24, 2026, Before Open (Confirmed).
Last Earnings DateJun 30, 2026
Next Earnings DateSep 24, 2026
Ex-Dividend Date―
Financial Position
Ramm Pharma as a current ratio of 0.74, with Debt / Equity ratio of ―
Current Ratio0.74
Quick Ratio0.48
Debt to Market Cap0.04
Net Debt to EBITDA0.19
Interest Coverage Ratio-17.59
Taxes
In the past 12 months, Ramm Pharma has paid 15.25K in taxes.
Income Tax15.25K
Effective Tax Rate>-0.01
Enterprise Valuation
Ramm Pharma EV to EBITDA ratio is -0.28, with an EV/FCF ratio of -1.01.
EV to Sales0.32
EV to EBITDA-0.28
EV to Free Cash Flow-1.01
EV to Operating Cash Flow-1.01
Balance Sheet
Ramm Pharma has C$803.88K in cash and marketable securities with C$61.30K in debt, giving a net cash position of C$723.49K billion.
Cash & Marketable SecuritiesC$803.88K
Total DebtC$61.30K
Net CashC$723.49K
Net Cash Per Share<C$0.01
Tangible Book Value Per ShareC$0.05
Margins
Gross margin is ―, with operating margin of -134.42%, and net profit margin of -265.13%.
Gross Margin―
Operating Margin-134.42%
Pretax Margin-264.68%
Net Profit Margin-265.13%
EBITDA Margin-112.56%
EBIT Margin-134.42%
Analyst Forecast
The average price target for Ramm Pharma is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-53.86%
EPS Growth Forecast36.41%